European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. Opening the session, moderator Tim Sandle highlighted six fundamental aspects of contamination control.

Consulting 123

Consulting Biopharma Manufacturing Pharmaceutical 123

pharmaphorum

DECEMBER 18, 2022

However, most models are based on an old-fashioned and expensive call centre-based approach that fails to meet the needs of patients and healthcare providers (HCPs) as consumers. Yet, the healthcare experience is antiquated. entertainment or consumer apps), before it is production-worthy for mission-critical healthcare applications.

Biopharma 87

Biopharma Patients Prescription Medical 87

Pharmaceutical Technology

JUNE 15, 2023

AI in pharma R&D is one of the latest innovations helping teams apply existing knowledge to new problems. Artificial intelligence (AI) has many implications for pharmaceutical companies, including on research, drug discovery and development, manufacturing and trials. Here are a few ways AI is used in pharma today.

Pharma 52

Pharma Management Networking Manufacturing 52

Pharma Marketing Network

JANUARY 12, 2023

FAIRFIELD, NJ (12 January, 2023) – The Healthcare Businesswomen’s Association (HBA) announces the 2023 Woman of the Year, Honorable Mentor, and STAR. The HBA Woman of the Year award honors a female senior executive whose accomplishments have resulted in significant contributions to the healthcare industry. Jag Dosanjh, President, U.S.

Healthcare 52

Healthcare Healthcare Networking Manufacturing 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time. Pharmaceutical Technology has listed the top speciality pharmacies in pharma based on its intel, insights, and decades of experience in the sector. .

Specialization 45

Specialization Leads Pharma Side effects 45

Clarivate

JULY 24, 2023

Biopharma and medtech brands made up a dozen of the Clarivate Top 100 New Brands for 2023, as the life science industries continued to show a muscular approach to protecting their intellectual property. The post Pharmas and medtechs flex brand protection among Top 100 New Brands for 2023 appeared first on Clarivate.

Pharma 52

Pharma Biopharma Prospecting Training 52

Pharmaceutical Technology

SEPTEMBER 13, 2022

The acquisition will expand the international solutions portfolio of AmerisourceBergen aiding in advancing its position as a preferred partner for biopharmaceutical manufacturers. This approach will support its manufacturer partners throughout the pharmaceutical development and marketing processes.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Consulting 52

pharmaphorum

AUGUST 4, 2022

This is due to the specialist nature of roles and the growth and diversification of biopharma, which requires an increasingly sophisticated and skilled workforce. Furthermore, by simulating real-life scenarios, AR offers the chance for staff in the pharma industry to practice complex operations without the associated risks.

Recruitment 91

Recruitment Pharma Training Pharmaceutical manufacturing 91

Pharmaceutical Technology

JULY 6, 2022

Just last week, trading for 4D Pharma , a British biotech, was suspended on the London Stock Exchange’s Alternative Investment Market , and the company will be delisted from NASDAQ on July 7. Other businesses such as Redhill Biopharma or Vincerx Pharma have also announced plans for large layoffs. Caution in the near future.

Marketing 129

Marketing Biopharma Pharma Retail 129

Scott Burrows

NOVEMBER 2, 2022

Like any other manufactured product, pharma and biopharma products are a sum of…

Pharmaceutical Sales 52

Pharmaceutical Sales Pharmaceutical Sales Biopharma 52

Clarivate

MAY 14, 2024

With only two3 GLP-1 drugs currently approved for weight loss—Huadong Medicine’s version of daily dosed liraglutide and thrice-a-day dosed beinaglutide from Benamae Pharma—the gap is substantial and leaves a solid market opportunity for weight loss drugs. What’s leading to the boom in development of semaglutide biosimilars?

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

PM360

SEPTEMBER 28, 2022

Now, as the President of Accord BioPharma , the U.S. Now that you’re responsible for launching biosimilars in today’s market, what are currently the biggest barriers or issues manufacturers and marketers face that impedes the success of their biosimilar products? But now the big pharma companies have also jumped into the game.

Competition 98

Competition Marketing Biopharma Manufacturing 98

Clarivate

NOVEMBER 17, 2021

In this episode of Conversations in Healthcare , Carolyn Hynes from AstraZeneca discusses the importance of regulatory intelligence. Mike Ward: Where in that medicines’ discovery development manufacturer, large delivery timeline, does regulatory intelligence have an impact? Subscribe to Conversations in Healthcare .

Pharma 52

Pharma Healthcare Healthcare Specialization 52

Pharma Marketing Network

JUNE 17, 2021

The Healthcare Businesswoman’s Association Europe region released an update to its 2018 industry gender pay gap report that shows there is a clear increase in the pay gap between men and women in the life sciences sector in Europe. France and the U.K. reduced the pay gap to 4.8 percent and 5.1 Get the Full Report.

Biopharma 52

Biopharma Healthcare Healthcare Networking 52

PM360

OCTOBER 3, 2023

PRODUCT LAUNCH OF THE YEAR NEXTSTELLIS (Mayne Pharma and EVERSANA INTOUCH) RELAUNCH/REVITALIZATION OF THE YEAR VRAYLAR (AbbVie Inc. Director, Obesity Market Access Strategy, Novo Nordisk Medical Device/Diagnostics: Brett Sarnoff, Vice President of Marketing Medical Device & Pharma Systems, North America, B. Braun Medical, Inc.

Education 122

Education Marketing Media Management 122

PM360

AUGUST 24, 2023

Each of their trailblazing efforts result in much more than personal or organization success, it results in better quality of life for patients, better care options for healthcare providers, and happier and healthier people around the world.” Weiss has also made substantial efforts to give back to the community at large.

Marketing 52

Marketing Education Media Healthcare 52

Pharmaceutical Technology

JULY 6, 2022

Just last week, trading for 4D Pharma , a British biotech, was suspended on the London Stock Exchange’s Alternative Investment Market , and the company will be delisted from NASDAQ on July 7. Other businesses such as Redhill Biopharma or Vincerx Pharma have also announced plans for large layoffs. Caution in the near future.

Marketing 64

Marketing Biopharma Pharma Retail 64

Clarivate

MARCH 14, 2024

1] To mitigate the potential presence of nitrosamine impurities in pharmaceuticals, manufacturers are now facing impending regulatory requirements in various markets – in the European Union, for example, they were obligated to submit reformulation strategies and mitigation plans in late 2022. [2].

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

PM360

DECEMBER 14, 2023

Moderna Joins CEPI Pandemic Preparedness Mission After making its debut in the pharma market during the COVID-19 pandemic, Moderna is preparing for the next pandemic. The pharma company has joined the Coalition for Epidemic Preparedness Innovations (CEPI) in a partnership that aims to shorten vaccine development timelines down to 100 days.

Physicians 52

Physicians Pharma Medical Patients 52

Pharmaceutical Technology

NOVEMBER 4, 2022

As visibility diminishes, mismanagement of the supply chain can not only lead to revenue and reputational damage for manufacturers but more importantly, loss of life for patients. The expertise in procurement for new projects is a definite advantage with choosing a CMO like Baxter BioPharma Solutions.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

Clarivate

OCTOBER 25, 2023

What the addition of Part B may bring With the expansion of price negotiations to include Part B drugs in 2028 , Medicare reimbursement may become challenging for additional manufacturers. B&B allows larger practices to negotiate for better reimbursement rates from commercial payers and larger manufacturer discounts/rebates.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

European Pharmaceutical Review

APRIL 30, 2024

What are the top three trends that you are seeing in the biopharma manufacturing space? This resulted in not only a mismatch in the required manufacturing scale but also a significant over capacity as well. Let’s talk about continuous biopharma manufacturing. What are the main challenges in this area in particular?

Manufacturing 78

Manufacturing Food and Drug Administration Biopharma Marketing 78

Pharmaceutical Technology

JULY 7, 2022

There is a lot of excitement that we could be at the start of a new era for the biopharmaceutical industry, with the hope of delivering revolutionary healthcare for previously unaddressed diseases finally becoming a reality. Using a similar treatment to target solid tumours could be the industry’s next major milestone.

Medicine 98

Medicine Transportation Manufacturing Biopharma 98

PM360

OCTOBER 5, 2023

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. Weiss has also made substantial efforts to give back to the community at large.

Education 52

Education Marketing Media Biopharma 52

eMediWrite

JUNE 6, 2022

The global pandemic has raised everyone’s awareness of the importance of healthcare. However, if you asked the same people who make such medicines, considerably fewer people would be able to respond with the right manufacturers’ company name. Introduction. But times have changed. Separartion is important.

Pharmaceutical 52

Pharmaceutical Pharma Marketing Medicine 52

Clarivate

JULY 5, 2023

In 2022, it made its manufacturer, AbbVie, $21.2bn. This strategy is often chosen by the brand manufacturers who offer higher rebates at the net price level in exchange for better placement on formularies. The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. The current U.S.

Marketing 97

Marketing Physicians Manufacturing Competition 97

European Pharmaceutical Review

SEPTEMBER 15, 2023

For its 20 th anniversary, more than 180 entries across 12 categories have been narrowed down to determine the finalists the upcoming CPHI Pharma Awards. To recognise the influx of innovation across the pharmaceutical industry, three new categories are included in this year’s awards. Are you coming to the CPHI Barcelona 2023?

Pharma 111

Pharma Manufacturing Biopharma Healthcare 111

Clarivate

MAY 24, 2022

The consortium aims to promote awareness for rare diseases within the healthcare community and general public, address the impending issue of drug availability and improve the quality of life of rare disease patients. Multinational pharmas seek entry for their products. Source: Mainland China’s Center for Drug Evaluation. References.

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

European Pharmaceutical Review

DECEMBER 21, 2022

Most psychedelic drugs are Schedule I controlled substances, which means that very strict legal and regulatory controls accompany their use” Some psychedelics originate in nature and have been used by Indigenous cultures for thousands of years; others are manipulated or manufactured. Get to know the manufacturing standards.

Food and Drug Administration 107

Food and Drug Administration Medicine Food Government 107

European Pharmaceutical Review

DECEMBER 19, 2022

Furthermore, the joint statement cites examples of successful switch of biological medicines manufactured and commercialised by different companies, which is stated to have become “common in clinical practice”. Chris was named a ‘Rising Star’ in the 2022 Legal 500 Rankings for Life Sciences and Healthcare. References/Endnotes.

Medicine 52

Medicine Biopharma Safety Food 52

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. That leaves three years for pharma companies to prepare. asked panel chair Ipsita Smolinski, MD of consultancy Capitol Street. .”

FDA 52

FDA Prescription Medicine Biopharma 52

PM360

SEPTEMBER 15, 2022

But battling information asymmetry is one of the best ways to address the ongoing inequities in our healthcare system. But to shift the industry’s approach to healthcare, all stakeholders must move the efforts, attention, and education necessary to find a common ground and ensure that the patients’ interests are always driving development.

Patients 98

Patients Healthcare Healthcare Marketing 98

European Pharmaceutical Review

OCTOBER 2, 2023

CPHI Barcelona, the renowned global pharma event, is set to take centre stage from 24 to 26 October 2023 at Fira Barcelona Gran Via, Spain. CPHI creates connections and inspires partnerships across the global pharma community. CPHI creates connections and inspires partnerships across the global pharma community.

Manufacturing 97

Manufacturing Pharma Engineering Networking 97

World of DTC Marketing

JUNE 8, 2021

They are going to allow Biogen NINE years for follow-up clinical trials in which time our healthcare system is going to pay a TON of money for hope. Here is what they had to say: “Despite support from patient advocacy groups and pressure from the manufacturer. It hasn’t yet been shown to work.

FDA 207

FDA Food and Drug Administration Patients Biopharma 207

Clarivate

AUGUST 8, 2023

The biopharma industry is sweating the long-term implications and warning that it could mean less lifesaving drugs make it to patients going forward. The law was top-of-mind at this summer’s ASCO and BIO meetings, tentpole events in the biopharma conference calendar. R&D efficiency is more critical than ever.

Biopharma 52

Biopharma Pharma Prescription Manufacturing 52

Clarivate

MAY 24, 2023

In recent years, FDA has increasingly shown an openness to surrogate endpoints as the basis for approval of a therapy,” said Bethany Kiernan, Director of Healthcare Research Analytics for Infectious, Niche and Rare Diseases at Clarivate.

Patients 52

Patients Food and Drug Administration Biopharma FDA 52

Pharmaceutical Technology

APRIL 24, 2023

Biologics are costly to produce and sell, and the more recent modalities, such as cell and gene therapies, can be difficult to manufacture. With new drugs on the market, companies are now looking for ways to manufacture recently approved biologics, and countries are racing to claim their corner – or maintain their decades-old market share.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52